3 Dec 2024

MASLD/MASH: Clinical and Economic Findings from 40-year Follow-Up Data

2024-12-04T16:34:27+01:00December 3, 2024|All, Other|

𝐌𝐀𝐒𝐋𝐃/𝐌𝐀𝐒𝐇: 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 40-𝐲𝐞𝐚𝐫 𝐅𝐨𝐥𝐥𝐨𝐰-𝐔𝐩 𝐃𝐚𝐭𝐚
On Tuesday December 10th, Quantify’s Emilie Toresson Grip is one of three speakers at ISPOR’s webinar on MASLD/ MASH following their BRIDGE-MASH study.

Moderated by Riku Ota, Global Payer Evidence Lead at […]

2 Oct 2024

Nordic RWE in FDA decision making

2024-10-02T15:54:31+02:00October 2, 2024|All, Other|

The use of Real-World Data (RWD) to support regulatory decisions is growing rapidly.
Several regulating agencies have in the past few years issued guidelines on the requirements on Real-World Evidence (RWE)-studies to be fit-for purpose for regulatory purposes.

Nordic data properties share […]

1 Oct 2024

COHERE Finland!

2024-10-02T15:59:02+02:00October 1, 2024|Other|

On September 17th, Quantify Finland participated in the Council for Choices in Health Care in Finland (COHERE Finland)10th anniversary seminar. The theme of the seminar was “Prioritization and the service portfolio in 2030.”
The day featured several thought-provoking presentations with highlights […]

27 Sep 2024

Delving into evidence synthesis?

2024-10-01T14:39:02+02:00September 27, 2024|Other|

PubMed®, Embase® and Google Scholar – what is the difference and when should I use each?
In the realm of HEOR, synthesizing evidence from diverse sources is crucial for informed decision-making.
Choosing the right database can significantly impact the quality and relevance […]

Go to Top